[96a5a0]: / output / chiaCancer / logical / NCT02222272_logical.json

Download this file

221 lines (221 with data), 9.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
{
"info": {
"nct_id": "NCT02222272",
"official_title": "Effect of Prior Therapy With Nilotinib or Dasatinib on the Outcome After Allogeneic Stem Cell Transplantation for Patients With Chronic Myeloid Leukaemia",
"inclusion_criteria": "* All adult patients with chronic myeloid leukaemia in any phase (chronic, accelerated or blastic) who undergo allogeneic stem cell transplantation between 01/01/2010 and 30/09/2013 and have been previously treated with Nilotinib or Dasatinib, regardless of their response to these drugs.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* All adult patients with chronic myeloid leukaemia in any phase (chronic, accelerated or blastic) who undergo allogeneic stem cell transplantation between 01/01/2010 and 30/09/2013 and have been previously treated with Nilotinib or Dasatinib, regardless of their response to these drugs.",
"criterions": [
{
"exact_snippets": [
"adult patients"
],
"criterion": "age",
"requirement_type": "category",
"expected_value": "adult"
},
{
"exact_snippets": [
"chronic myeloid leukaemia"
],
"criterion": "chronic myeloid leukaemia",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"chronic myeloid leukaemia",
"in any phase (chronic, accelerated or blastic)"
],
"criterion": "chronic myeloid leukaemia phase",
"requirement_type": "category",
"expected_value": [
"chronic",
"accelerated",
"blastic"
]
},
{
"exact_snippets": [
"undergo allogeneic stem cell transplantation"
],
"criterion": "allogeneic stem cell transplantation",
"requirement_type": "procedure",
"expected_value": true
},
{
"exact_snippets": [
"between 01/01/2010 and 30/09/2013"
],
"criterion": "transplantation date",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 20100101
},
{
"operator": "<=",
"value": 20130930
}
]
}
},
{
"exact_snippets": [
"previously treated with Nilotinib or Dasatinib"
],
"criterion": "treatment",
"requirement_type": "previous",
"expected_value": [
"Nilotinib",
"Dasatinib"
]
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"adult patients"
],
"criterion": "age",
"requirement_type": "category",
"expected_value": "adult"
},
{
"exact_snippets": [
"chronic myeloid leukaemia"
],
"criterion": "chronic myeloid leukaemia",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"chronic myeloid leukaemia",
"in any phase (chronic, accelerated or blastic)"
],
"criterion": "chronic myeloid leukaemia phase",
"requirement_type": "category",
"expected_value": [
"chronic",
"accelerated",
"blastic"
]
},
{
"exact_snippets": [
"undergo allogeneic stem cell transplantation"
],
"criterion": "allogeneic stem cell transplantation",
"requirement_type": "procedure",
"expected_value": true
},
{
"exact_snippets": [
"between 01/01/2010 and 30/09/2013"
],
"criterion": "transplantation date",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 20100101
},
{
"operator": "<=",
"value": 20130930
}
]
}
},
{
"exact_snippets": [
"previously treated with Nilotinib or Dasatinib"
],
"criterion": "treatment",
"requirement_type": "previous",
"expected_value": [
"Nilotinib",
"Dasatinib"
]
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}